[go: up one dir, main page]

CY1108048T1 - Συνθεση σπογγοσινης - Google Patents

Συνθεση σπογγοσινης

Info

Publication number
CY1108048T1
CY1108048T1 CY20081100268T CY081100268T CY1108048T1 CY 1108048 T1 CY1108048 T1 CY 1108048T1 CY 20081100268 T CY20081100268 T CY 20081100268T CY 081100268 T CY081100268 T CY 081100268T CY 1108048 T1 CY1108048 T1 CY 1108048T1
Authority
CY
Cyprus
Prior art keywords
spongosin
composition
methoxyadenine
benzoyl
tri
Prior art date
Application number
CY20081100268T
Other languages
English (en)
Inventor
Jacqueline Valerie Anne Ouzman
Original Assignee
Cambridge Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Biotechnology Ltd filed Critical Cambridge Biotechnology Ltd
Publication of CY1108048T1 publication Critical patent/CY1108048T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Silicon Polymers (AREA)
  • Catalysts (AREA)

Abstract

Περιγράφεται αντίδραση 1-Ο-ακετυλο-2,3,5-τρι-O-βενζοϋλο-β-D-ριβοφουρανόζης με 2-μεθοξυ-αδενίνη προς σχηματισμό 9-(2',3',5'-τρι-O-βενζοϋλο-β-D-ριβοφουρανοζυλο)-2-μεθοξυ-αδενίνης, και η εν συνεχεία αποπροστασία της 9-(2',3',5'-τρι-O-βενζοϋλο-β-D-ριβοφουρανοζυλο)-2-μεθοξυ-αδενίνης, για να σχηματισθεί η σπογγοσίνη. Περιγράφεται επίσης η σύνθεση ενδιάμεσων προς χρήση στην σύνθεση της σπογγοσίνης.
CY20081100268T 2004-01-21 2008-03-07 Συνθεση σπογγοσινης CY1108048T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0401292.8A GB0401292D0 (en) 2004-01-21 2004-01-21 Synthesis of spongosine
EP05701948A EP1709057B1 (en) 2004-01-21 2005-01-19 Synthesis of spongosine

Publications (1)

Publication Number Publication Date
CY1108048T1 true CY1108048T1 (el) 2013-09-04

Family

ID=31971211

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100268T CY1108048T1 (el) 2004-01-21 2008-03-07 Συνθεση σπογγοσινης

Country Status (19)

Country Link
US (1) US20100216991A1 (el)
EP (1) EP1709057B1 (el)
JP (1) JP2007518782A (el)
KR (1) KR20060132910A (el)
CN (1) CN1910194B (el)
AT (1) ATE381572T1 (el)
AU (1) AU2005206361A1 (el)
CA (1) CA2552552A1 (el)
CY (1) CY1108048T1 (el)
DE (1) DE602005003922T2 (el)
DK (1) DK1709057T3 (el)
ES (1) ES2298998T3 (el)
GB (1) GB0401292D0 (el)
HK (1) HK1099026A1 (el)
NO (1) NO20063715L (el)
NZ (1) NZ548220A (el)
PL (1) PL1709057T3 (el)
PT (1) PT1709057E (el)
WO (1) WO2005070947A1 (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070004792A (ko) * 2004-03-05 2007-01-09 캠브리지 바이오테크놀로지 리미티드 아데노신 수용체 작용제
US9580457B2 (en) 2012-10-29 2017-02-28 Biophore India Pharmaceuticals Pvt. Ltd. Process for the preparation of (1-{9-[(4S, 2R, 3R, 5R)-3, 4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-6-aminopurin-2-yl}pyrazole-4-yl)-N-methylcarboxamide
CN103342727A (zh) * 2013-07-01 2013-10-09 淮海工学院 一种2-甲氧基腺苷的合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030008841A1 (en) * 2000-08-30 2003-01-09 Rene Devos Anti-HCV nucleoside derivatives

Also Published As

Publication number Publication date
JP2007518782A (ja) 2007-07-12
EP1709057A1 (en) 2006-10-11
DE602005003922D1 (de) 2008-01-31
NZ548220A (en) 2009-12-24
PT1709057E (pt) 2008-03-10
KR20060132910A (ko) 2006-12-22
GB0401292D0 (en) 2004-02-25
AU2005206361A1 (en) 2005-08-04
CN1910194B (zh) 2010-05-05
ES2298998T3 (es) 2008-05-16
ATE381572T1 (de) 2008-01-15
WO2005070947A1 (en) 2005-08-04
PL1709057T3 (pl) 2008-05-30
DE602005003922T2 (de) 2008-12-04
DK1709057T3 (da) 2008-04-28
CA2552552A1 (en) 2005-08-04
EP1709057B1 (en) 2007-12-19
US20100216991A1 (en) 2010-08-26
CN1910194A (zh) 2007-02-07
HK1099026A1 (en) 2007-08-03
NO20063715L (no) 2006-08-18

Similar Documents

Publication Publication Date Title
MX2007014132A (es) Compuestos de diarilhidantoina.
CL2008003398A1 (es) Compuestos derivados de bis-(sulfonilamino); procedimientos de sintesis; composiciones farmaceuticas que los comprende; proceso de preparacion de las composiciones farmaceuticas; y su uso en el tratamiento de osteoartritis, artritis reumatoide, neoplasias dolor agudo o cronica, enfermedad de alzheimer, entre otras.
NO20080129L (no) Fremgangsmate for fremstilling av dihydrokinazoliner
CY1116768T1 (el) Συνθεσεις οι οποιες περιεχουν βλαστοκυτταρα θηλυκης γαμετικης σειρας και μεθοδοι χρησης αυτων
ECSP088221A (es) Agonistas adrenoreceptores alfa2c
CL2008000670A1 (es) Compuestos derivados de tiazolidindionas y oxazolidindionas sustituidas; composicion farmaceutica; proceso de preparacion de la composicion farmaceutica; y uso en el tratamiento de enfermedades tales como artritis reumatoide, epoc, cancer, entre otras.
ATE524476T1 (de) Pyrazolopyrimidine als modulatoren von caseinkinase ii (ck2)
ECSP056111A (es) Derivados de 2-acilamino-4-feniltiazol, su preparación y aplicación en terapeutica
TW200716584A (en) Dihydrobenzofuran derivatives and uses thereof
SE0301653D0 (sv) Novel compounds
EA200870514A1 (ru) Ацетиленовые гетероарильные соединения
TW200745122A (en) New compounds I
UA83311C2 (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
MX2009004435A (es) Tinturas dispersas, su preparacion y su uso.
DE602006009789D1 (de) Acetylenderivate
MEP1008A (xx) 3-aminociklopentankarboksamidi kao modulatori receptora hemokina
BRPI0508700A (pt) uso de sns-595, composição farmacêutica, e, pó liofilizado
CL2007000789A1 (es) Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer.
TW200608966A (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
TW200716564A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
HRP20090513T1 (en) S-mirtazapine for the treatment of hot flush
CR9853A (es) Compuestos de exemestano (s)-6-metiloxaalquilo y metodos relacionados con su utilizacion
EP1667716B8 (en) Cytotoxicity mediation of cells evidencing surface expression of cd44
CY1108156T1 (el) Στερεοεκλεκτικη συνθεση αναλογων βιταμινης d
UY29036A1 (es) Derivados de oxopiperidina, su preparacion y su aplicacion en terapeutica